Barry Teater

Meet CEO David King, the practical strategist who’s driving LabCorp’s ‘tremendous run’

Posted by Barry Teater | Feb 28, 2018

In January LabCorp was named to Fortune magazine’s list of the “World’s Most Admired Companies.” Last year it was named to Forbes’ ranking of the “World’s Most Innovative Companies.” The Burlington-based company continues to grow in size and reputation. And driving LabCorp ever higher is David King, its chair and CEO, who talks about the “tremendous run” of the life science giant under his direction.

Novo Nordisk plans $65M expansion of Clayton manufacturing site

Posted by Barry Teater | Feb 21, 2018

The global diabetes and obesity epidemic is driving another expansion of Novo Nordisk’s drug-manufacturing operations at its 264-acre campus in Clayton.

Kepley BioSystems selected to present at national small business showcase

Posted by Barry Teater | Feb 9, 2018

Greensboro-based Kepley BioSystems, developer of a reusable, synthetic bait for the lobster and crab fisheries and other marine technologies, is one of only 11 U.S. companies invited to America’s Small Business Development Center Client Showcase

Bioventus invests $2.5M in Israeli joint implant company CartiHeal

Posted by Barry Teater | Feb 9, 2018

Bioventus, a global orthobiologics company headquartered in Durham, has invested $2.5 million in an Israeli company that has developed an implant for treating osteoarthritic knees.

Citing tech, product potential, former QuintilesIMS exec joins Liquidia as president, CFO

Posted by Barry Teater | Feb 8, 2018

Kevin Gordon, a former senior executive at QuintilesIMS, is joining Liquidia as its president and chief operating officer. Here’s why.

Lessons for entrepreneurs: How DisposeRX, a small NC tech startup, made a big deal with Walmart

Posted by Barry Teater | Feb 6, 2018

For William Simpson, it’s no secret how his small startup company, DisposeRx, in Southern Pines scored a major product placement with retail giant Walmart. He shares his story so other entrepreneurs might cash in, too, with their own ideas.

Training program for pharmaceutical manufacturing opens in Greenville

Posted by Barry Teater | Feb 2, 2018

A hands-on program to train workers for good-paying jobs in pharmaceutical manufacturing officially opened this week in Greenville to the applause of economic developers, industry executives and leaders in government and academia.

Durham’s Biomarck Pharmaceuticals launches Phase 2 clinical trial for lung cancer treatment

Posted by Barry Teater | Jan 25, 2018

Durham-based Biomarck Pharmaceuticals has launched a Phase 2 clinical trial of a potential therapy for treating advanced non-small cell lung cancer.

BioCryst Pharmaceuticals to merge with Idera Pharma; firm to be based in Pennsylvania

Posted by Barry Teater | Jan 22, 2018

Durham-based BioCryst Pharmaceuticals has signed a definitive merger agreement with Idera Pharmaceuticals. Biocryst board chair Bob Ingram will lead the board of the merged firm.

Posts by Barry Teater